Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
TECH

Market Cap: $11.29B

BC

Bio-Techne Corporation

TECH

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin65.77%

EBITDA Margin28.27%

EBIT Margin20.25%

Pre-tax Margin19.81%

Net Profit Margin14.97%

Earnings Yield1.62%

Valuation Multiples

Price / Book5.34

Price / Sales9.29

Price / Earnings61.64

PEG0.40

Forward PEG4.45

EV / Sales9.31

EV / EBITDA32.95

EV / Operating Cash Flow38.74

EV / Free Cash Flow42.99

Price / Free Cash Flow42.90

Price / Operating Cash Flow38.51

Cash Flow & Capital

Free Cash Flow / Share$1.69

Operating Cash Flow / Share$1.87

Free Cash Flow Yield2.33%

Capex / Revenue2.37%

Capex / Operating Cash Flow9.88%

Capex / Depreciation0.30

Stock Compensation / Revenue3.40%

Dividend Payout Ratio27.45%

Dividend Yield0.44%

Liquidity & Leverage

Current Ratio4.55

Quick Ratio3.35

Cash Ratio1.62

Debt / Assets0.11

Debt / Capital0.12

Debt / Equity0.14

Long-Term Debt / Capital0.09

Debt / Market Cap1.77%

Net Debt / EBITDA0.07

Solvency Ratio0.58

Financial Leverage1.23

Efficiency & Working Capital

Asset Turnover0.47

Fixed Asset Turnover4.06

Inventory Turnover2.13

Receivables Turnover5.61

Payables Turnover3.96

Days Sales Outstanding65.06

Days Inventory Outstanding171.76

Days Payables Outstanding92.2

Operating Cycle236.82

Cash Conversion Cycle144.62

Working Capital Turnover2.18

Returns & Quality

Return on Equity8.90%

Return on Assets7.03%

Return on Invested Capital7.81%

ROCE10.40%

Return on Tangible Assets13.90%

Operating Return on Assets9.81%

Income Quality1.61

Tax Burden0.76

Interest Burden0.98

Balance Sheet & Intrinsic Metrics

Enterprise Value$11.32B

Invested Capital$2.16B

Working Capital$580.7M

Tangible Asset Value$829.4M

Net Current Asset Value$265.9M

Graham Number$18.83

Graham Net-Net$0.3

Book Value / Share$13.52

Tangible Book Value / Share$5.32

Cash / Share$1.7

Financial Health Scores

Piotroski Score8

Altman Z-Score15.88

Revenue$1.22B

EBIT$246.09M

Market Cap$11.33B

Working Capital$580.7M

Retained Earnings$1.14B

Total Assets$2.59B

Total Liabilities$478.51M